First Trust Advisors’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-285
Closed -$44K 2586
2022
Q2
$44K Sell
285
-8
-3% -$3.66K ﹤0.01% 2478
2022
Q1
$193K Sell
293
-14
-5% -$7.46K ﹤0.01% 2477
2021
Q4
$179K Buy
307
+39
+15% +$28.3K ﹤0.01% 2471
2021
Q3
$144K Sell
268
-202
-43% -$98.7K ﹤0.01% 2484
2021
Q2
$187K Sell
470
-17
-3% -$5.54K ﹤0.01% 2436
2021
Q1
$138K Buy
487
+50
+11% +$14.7K ﹤0.01% 2394
2020
Q4
$103K Sell
437
-19
-4% -$4.8K ﹤0.01% 2296
2020
Q3
$130K Buy
+456
New +$144K ﹤0.01% 2272

Other funds holding LNAI

First Trust Advisors's LNAI Position: Q3 2022 in Review

First Trust Advisors sold out of Lunai Bioworks (LNAI) in Q3 2022, closing a stake of 285 shares — an estimated $44K sold.

First Trust Advisors first reported a position in LNAI in Q3 2020 and held it in 8 quarters. The position peaked at $193K in Q1 2022. 42 funds tracked by Wall St. Rank hold LNAI as of Q3 2022.

  • First Trust Advisors reported no remaining Lunai Bioworks position as of Q3 2022 after selling out during the quarter.
  • First Trust Advisors sold 285 Lunai Bioworks shares in Q3 2022, an estimated $44K.
  • First Trust Advisors first reported a position in Lunai Bioworks in Q3 2020 and held it in 8 quarters.
  • First Trust Advisors's Lunai Bioworks position peaked at $193K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2022.

Based on First Trust Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.